Premium Service · Flagship

C-Suite Executive Assessment & Leadership Advisory

A board-level assessment of strategic leadership, healthcare leadership, governance and executive presence — for CEOs, Group CEOs, Medical Directors, COOs, CMOs and family-business leaders.

A premium, board-level advisory service

Healthcare and family-enterprise leadership carries a particular kind of pressure: the decisions are clinical and commercial, immediate and generational, all at once. The C-Suite Executive Assessment gives boards, chairmen and executives themselves an independent, structured view of leadership capability — not a performance review, but a strategic diagnostic built for people who already carry significant responsibility.

What the assessment evaluates

  • Strategic thinking and decision-making under complexity
  • Leadership capability and emotional intelligence
  • Executive presence and stakeholder management
  • Governance awareness and board-level fluency
  • Operational and financial awareness
  • Organizational impact and transformation capability
  • Succession readiness — for the individual and the organization around them

Who this is for

  • CEOs and Group CEOs of healthcare organizations
  • Medical Directors and Group Medical Directors
  • COOs and CMOs
  • Family-business leaders and next-generation successors
  • Boards conducting independent leadership review as part of governance practice

How it is delivered

Every assessment is structured around the same disciplined methodology, adapted to the individual and the organization's context.

01

Diagnose

Structured assessment across strategic, operational and interpersonal dimensions.

02

Design

A clear, confidential summary of strengths and development priorities.

03
Deliver

A focused action plan — typically a 90-day horizon — with concrete priorities.

04
Sustain

Optional ongoing advisory support to embed the plan into real decisions.

Confidentiality is central to this service. Assessment findings are shared only with the individual and, where the engagement is board-commissioned, a board-level summary agreed in advance. Scope and fees are confirmed after an initial confidential consultation.